Accurate identification of clinically important Acinetobacter spp.: an update

Area of Science:

• Clinical microbiology
• Bacterial identification
• Antimicrobial resistance

Background:

• Acinetobacter species are significant opportunistic pathogens.
• Current phenotypic identification methods for Acinetobacter species are often insufficient, especially for closely related species.
• Accurate differentiation is critical for effective treatment and infection control.

Purpose of the Study:

• To review and compare various methods for identifying and differentiating Acinetobacter species.
• To highlight the limitations of conventional phenotypic techniques.
• To emphasize the advantages of molecular and mass spectrometry-based approaches.

Main Methods:

• Discussion of conventional phenotypic methods.
• Evaluation of automated identification systems.
• Analysis of molecular techniques (e.g., blaOXA-51-like PCR, rpoB sequencing).
• Assessment of MALDI-TOF mass spectrometry.

Main Results:

• Phenotypic methods show limitations in discriminating closely related Acinetobacter species.
• Molecular methods, specifically blaOXA-51-like PCR and rpoB sequencing, demonstrate high discriminatory power.
• MALDI-TOF offers potential for rapid and accurate identification.

Conclusions:

• Molecular techniques provide superior accuracy for Acinetobacter species identification compared to phenotypic methods.
• Accurate differentiation is essential for managing infections caused by clinically important Acinetobacter species, particularly within the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
• Further validation and implementation of advanced methods are recommended.